Forbes March 21, 2024
Bruce Japsen

Digital diabetes management tools “fail to deliver meaningful benefits to patients” while at the same time increasing the cost of healthcare to consumers, health insurers and taxpayers, a new report finds.

Digital diabetes management solutions, which connect a “noncontinous glucose monitor” that can transmit data to a phone, computer or electronic record for tracking purposes, “consistently demonstrate that they help patients achieve small reductions in HbA1c beyond what they would achieve with usual care, but the evidence rarely reported improvement that exceeded commonly-used thresholds for meaningful clinical benefit,” said the Peterson Health Technology Institute.

“These solutions are used by millions of Americans and have been funded by $58 billion of investment and mergers and acquisitions, yet the evidence shows...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Digital Health, Insurance, Patient / Consumer, Provider, Survey / Study, Technology, Trends
OpenAI Launches ChatGPT Support for More Apple Desktop Apps
Every Choice Matters: Data Security And Privacy On AI-Enabled Apps
10 New AI Apps That Deserve Your Attention
AI-enabled apps top ECRI’s list of health tech hazards in 2025
Opinion: Mental health apps need a complete redesign

Share This Article